{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T11:58:55Z","timestamp":1705319935966},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.lpm.2014.05.024","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T15:32:15Z","timestamp":1418398335000},"page":"65-69","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Angi\u0153d\u00e8mes \u00e0 bradykinines et hormones"],"prefix":"10.1016","volume":"44","author":[{"given":"Anne","family":"Gompel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2014.05.024_bib0005","first-page":"447","article-title":"Genomic effects of estradiol in angioedema. Implications for contraception and hormonal menopause treatment","volume":"48","author":"Gompel","year":"2008","journal-title":"Rev Fr Allergol"},{"key":"10.1016\/j.lpm.2014.05.024_bib0010","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/annonc\/mdp295","article-title":"Tamoxifen contraindicated in women with hereditary angioedema?","volume":"20","author":"Rousset-Jablonski","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lpm.2014.05.024_bib0015","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","article-title":"Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond","volume":"114","author":"Agostoni","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.lpm.2014.05.024_bib0020","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mai.2000.108106","article-title":"Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema","volume":"106","author":"Binkley","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.lpm.2014.05.024_bib0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2014.05.024_bib0030","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1067\/mai.2001.114242","article-title":"Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission","volume":"107","author":"Martin","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.lpm.2014.05.024_bib0035","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9343(02)01526-7","article-title":"Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy","volume":"114","author":"Bork","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2014.05.024_bib0040","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1016\/j.ajog.2008.04.034","article-title":"Disease expression in women with hereditary angioedema","volume":"199","author":"Bouillet","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.lpm.2014.05.024_bib0045","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1398-9995.2010.02368.x","article-title":"Hereditary angioedema type III: clinical and biological features in a French cohort","volume":"65","author":"Vitrat-Hincky","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.lpm.2014.05.024_bib0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/cea.12055","article-title":"Benefits of progestin contraception in non-allergic angioedema","volume":"43","author":"Saule","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.lpm.2014.05.024_bib0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2010.08.012","article-title":"Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients","volume":"83","author":"Chabbert-Buffet","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.lpm.2014.05.024_bib0060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejogrb.2010.05.008","article-title":"The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey","volume":"152","author":"Czaller","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.lpm.2014.05.024_bib0065","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.ajog.2010.03.003","article-title":"Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate","volume":"203","author":"Martinez-Saguer","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.lpm.2014.05.024_bib0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2265.2006.02704.x","article-title":"Treatment of hereditary angioneurotic oedema (HANE) with tibolone","volume":"66","author":"Ott","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.lpm.2014.05.024_bib0075","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/gme.0b013e318247f07a","article-title":"Oral micronized progesterone for vasomotor symptoms: a placebo-controlled randomized trial in healthy postmenopausal women","volume":"19","author":"Hitchcock","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.lpm.2014.05.024_bib0080","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1055\/s-0038-1657871","article-title":"Increased englobulin fibrinolytic potential in women on oral contraceptives low in oestrogen levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII and C1 inactivator","volume":"54","author":"Jespersen","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2014.05.024_bib0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0049-3848(81)90206-1","article-title":"C1 inactivator level in pregnancy","volume":"23","author":"Ogston","year":"1981","journal-title":"Thromb Res"},{"key":"10.1016\/j.lpm.2014.05.024_bib0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0167-4781(93)90294-N","article-title":"The 5\u2019 sequence of human factor XII gene contains transcription regulatory elements typical of liver specific, estrogen-modulated genes","volume":"1172","author":"Citarella","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.lpm.2014.05.024_bib0095","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/509899","article-title":"Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III","volume":"79","author":"Cichon","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.lpm.2014.05.024_bib0100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0049-3848(91)90343-U","article-title":"Contact activation factors in plasma from women using oral contraceptives: increased levels of factor XII, kinin-free high molecular weight kininogen and acetone-activated kallikrein","volume":"64","author":"Hoem","year":"1991","journal-title":"Thromb Res"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821400517X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821400517X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T21:44:32Z","timestamp":1598564672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075549821400517X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S075549821400517X"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2014.05.024","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angi\u0153d\u00e8mes \u00e0 bradykinines et hormones","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}